Clinical Trials Browser

Phase 2 × Breast Cancer Metastatic × 90 days × Clear all

NCT06750484 2026-05-06

Trial of Trastuzumab Deruxtecan in Previously Treated HER2

Phase 2 Recruiting

Breast Cancer Metastatic